Could the federal government finally be creating something like the startup visa, the long-stalled immigration reform that would make it easier for entrepreneurs from foreign countries to start companies in the U.S.?
The door to that possibility might have opened slightly... Read more »
N30 Pharmaceuticals, a Boulder-based pharmaceutical company developing drugs for cystic fibrosis, announced yesterday it has raised a $30 million mezzanine financing round. N30 Pharma will use the funds to continue clinical trials for N91115, for which it recently completed a... Read more »
Shares of Clovis Oncology dropped 10 percent this morning following the release of interim results for the ongoing trial of the company’s drug for lung cancer patients.
Analysts said results failed to meet earlier estimates or show the drug is clearly... Read more »
Well care vs. sick care. The “patient-to-consumer revolution.” Smart care.
If you’re familiar with digital healthcare but aren’t an insider, you’ve probably heard these terms—quite possibly often enough to wonder if they’re buzzwords or actually represent concepts and trends worth learning... Read more »
[Corrected 11/17/14, 12:30pm. See below.] If nothing else, the acronym RNAi, which stands for ribonucleic acid interference, should be familiar to biotech observers as something that won two researchers the Nobel Prize in 2006, and that a few... Read more »
Craftsy continues its march to take over the e-learning world, one online instructional video—and megabucks funding round—at a time.
The Denver-based company announced it has closed a $50 million Series D round led by the Stripes Group, a New York City-based... Read more »
It will still be chilly next week in Colorado, but a few dozen leading startups and tech companies in Boulder plan to give more than 700 people a warm welcome.
On Tuesday, 42 companies including Google, Zayo Group, and Rally Software... Read more »